Abstract
A pair of novel enantiomers metarrhiziumoids A (R-enantiomer, 14.3 mg) and B (S-enantiomer, 9.5 mg) were isolated from 3.0 g extract of Metarhizium flavoviride by silica gel column chromatography combined with preparative and semi-preparative HPLC, and identified with high resolution mass, 1D, 2D NMR and circular dichroism. Targets prediction showed that the two compounds had glycosidase inhibitory activity. Result of α-glycosidase inhibitory tests showed that the both enantiomers were competitive inhibitors of α-glycosidase, and the bioactivity of metarrhiziumoids B (IC50 = 174 μg/mL) was stronger than that of metarrhiziumoids A (IC50 = 259 μg/mL). Molecular docking results show that the two enantiomers have different optimal docking modes and the binding energy for the S-enantiomer (-7.8 kcal/mol) was lower than for the R-enantiomer (-7.20 kcal/mol). The docking mode selections and binding energy differences resulted in the inhibitory activity difference.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
